Empowered Patient Podcast

Greg Sturmer, Co-Founder and CEO of Elysium Therapeutics, a company with expertise in reducing pain and addressing opioid use disorder and fatal overdose from fentanyl. Elysium has developed O2P, Oral Overdose Protection, a technology that aims to control the impact of opioids and reduce the risk of use disorder or a fatal overdose. SOOPR is a rescue agent designed specifically for overdoses from synthetic opioids, particularly fentanyl, which can last longer and be more potent than traditional opioids. Greg explains, "Anytime there’s an epidemic, you want to control exposure. The tricky bit in the area of pain management and the use of opioids is how do you control exposure without affecting patient care. We’ve come up with a technology that maintains the unmatched efficacy of the opioids. But when somebody takes too many pills, and we’ve actually shown this in our human study, we can reduce the exposure because we use this proprietary molecular delivery system that uses the body’s natural digestive process